Depressive Disorder, Major: all 2,805 studies

Page 28 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic CapacityCompletedNCT00205946Phase 1
• Behavioral Processes Underlying Reward Processing in DepressionCompletedNCT00205933
• Treatment for Chronic DepressionTerminatedNCT00204152Phase 3
• Treatment Choices for Improving Adherence and OutcomeCompletedNCT00194948Not applicable
• Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
• A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
• Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
• A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
• Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment ResponseCompletedNCT00188396Not applicable
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?CompletedNCT00186264Not applicable
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersTerminatedNCT00182533Phase 4
• Sertraline vs. Venlafaxine XRCompletedNCT00179283Phase 3
• The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to EscitalopramCompletedNCT00179257Phase 3
• Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar DisorderCompletedNCT00179062Not applicable
• Treatment of Major Depressive Disorder With Psychotic Features.TerminatedNCT00174590Phase 3
• Risperidone Augmentation Therapy in Patients Who Have Failed or Only Partially Responded to a Trial of AntidepressantStatus unknownNCT00174577Phase 3
• The Neurobiology of Depressive IllnessStatus unknownNCT00168493Not applicable
• A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive DisorderCompletedNCT00168376Not applicable
• Priming rTMS In Major DepressionCompletedNCT00168272Not applicable
• Risperidone and Suicidality in Major Depressive DisorderCompletedNCT00167154Phase 3
• The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDDCompletedNCT00163059Phase 2
• Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major DepressionTerminatedNCT00159146Not applicable
• Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.CompletedNCT00158990Phase 3
• Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in DepressionCompletedNCT00157547Phase 4
• Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive TherapyCompletedNCT00150839Phase 4
• Chronos: the Use of Chronobiological Treatment in DepressionCompletedNCT00149110Not applicable
• Transcranial Magnetic Stimulation (rTMS) Accelerates the Response to Escitalopram in Major DepressionCompletedNCT00149071Not applicable
• An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00146523Phase 3
• Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive DisorderTerminatedNCT00143091Phase 2
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive DisorderCompletedNCT00135421Phase 1/2
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00130676Phase 3
• An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128505Phase 3
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128479Phase 3
• Metyrapone as Additive Treatment in Major DepressionCompletedNCT00125554Phase 2
• Deep Brain Stimulation for Treatment-Refractory Major DepressionCompletedNCT00122031Phase 1
• Dopamine Receptor Imaging in Mood DisordersCompletedNCT00116077
• Comparison of Escitalopram Combination in Adult Patients With Major Depressive DisorderCompletedNCT00109044Phase 3
• Study of Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00108979Phase 3
• Study Comparing Two Types of Psychotherapy for Treating Depression and Substance AbuseCompletedNCT00108407Not applicable
• Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive DisorderCompletedNCT00104611Phase 3
• Study Of GW679769 In Major Depressive DisorderCompletedNCT00102492Phase 2
• Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood DisordersCompletedNCT00097175
• Cognitive Behavioral Therapy for Early-Onset DepressionCompletedNCT00096642Not applicable
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095823Phase 3
• A Study of Adjunctive Aripiprazole in Participants With Major Depressive DisorderCompletedNCT00095758Phase 3
• A Long-Term Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095745Phase 3
• Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyCompletedNCT00095134Phase 3
• Major Depressive Disorder In The ElderlyCompletedNCT00093288Phase 3
• Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
• Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
• Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
• Neurocardiac Control in Major DepressionCompletedNCT00084162
• FMRI Study of Performance During a Probabilistic Reversal Learning Task in DepressionCompletedNCT00075296
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
• A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive DisorderCompletedNCT00073203Phase 2
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical TrialApproved for marketingNCT00071708
• Evaluating Brain Responses to Facial Expressions in Major Depressive DisorderCompletedNCT00071123
• Depression Study In Elderly PatientsCompletedNCT00067444Phase 3
• PUFA Augmentation in Treatment of Major DepressionCompletedNCT00067301Phase 3
• Lethargic Depression StudyCompletedNCT00064467Phase 3
• Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3
• Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
• Brain Regulation of Emotions in People With Depression and AnhedoniaCompletedNCT00059579
• An 8 Week Depression Study In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057239Phase 2
• An 8 Week Study Of Adults Diagnosed With Major Depressive DisorderCompletedNCT00057226Phase 2
• An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057213Phase 2
• Effects Of Antidepressants On Sexual Functioning In AdultsCompletedNCT00051272Phase 3
• Effects of Antidepressants on Sexual FunctioningCompletedNCT00051259Phase 3
• Major Depressive Disorder Study In AdultsCompletedNCT00049972Phase 4
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)CompletedNCT00048607Phase 3
• Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)CompletedNCT00048594Phase 3
• A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive DisorderCompletedNCT00048204Phase 2
• MRI Study of Brain Activity and Risk for Depression in AdolescentsCompletedNCT00047944
• Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4
• A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNCT00044681Phase 3
• Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
• Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
• Examination of a Soy-Based Supplement for Major DepressionCompletedNCT00042380Phase 2
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)CompletedNCT00042029Phase 3
• Clinical Trial of Memantine for Major DepressionCompletedNCT00040261Phase 3
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3
• The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)CompletedNCT00035295Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)CompletedNCT00035282Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)CompletedNCT00035048Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)CompletedNCT00035009Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)CompletedNCT00034983Phase 3
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)CompletedNCT00034944Phase 3
• Serotonin Function During DepressionCompletedNCT00033787
• Riluzole to Treat Major DepressionCompletedNCT00026052Phase 2
• Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress DisorderCompletedNCT00025974
• Brain Function in Mentally Ill AdolescentsCompletedNCT00025857
• Treatment for Adolescents With Depression Study (TADS)CompletedNCT00006286Phase 3
• Treatment of Major Depression With St. John's Wort (Hypericum)CompletedNCT00005013Not applicable
• Heart Disease Risk Factors in Major DepressionCompletedNCT00001969
• Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in DepressionCompletedNCT00001916
• Dynamics of Leptin and Endocrine FunctionCompletedNCT00001543

← Depressive Disorder, Major overview